Bloom Energy Races Ahead of Its Peers on 20% Weekly Pop
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Bloom Energy enters the first week of September with its sharpest weekly gain in months, a sprawling lead over its closest competitors, and a short base that has been quietly unwinding — a combination that makes the stock's risk-reward unusually interesting right now.
The standout fact is the price action. BE closed at $252.87 on Friday, up 20% on the week and 7.4% on Thursday alone. That compares starkly with the peer group: VRT gained 9% on the week and GNRC added under 2%, while fuel-cell peer FCEL dropped nearly 16%. BE's year-to-date gain is tracking close to 171% by recent estimates, a move that reflects genuine long-side conviction rather than any squeeze dynamic — the borrow market is far too loose for that story.
Positioning reinforces that read. Short interest at 7.8% of the free float is meaningful but not extreme, and the direction of travel is down: the short count fell from around 20.5 million shares in mid-August to 18.5 million today, a drop of roughly 10% over three weeks. Borrow costs are negligible at 0.32% annualised — barely above zero — and availability is exceptionally wide at over 3,400%, meaning there are roughly 34 shares available to lend for every share currently borrowed. That's an enormous cushion, well above even the 52-week tightest point of 123%. The options market adds little tension: the put/call ratio of 1.04 is almost exactly in line with its 20-day average, with a z-score near zero. There is no unusual hedging pressure, no sign of crowded shorts, and no borrow squeeze in sight. What IS notable is that availability tightened sharply this week — down 44% in seven days — suggesting demand for borrows is picking up even as the overall lending pool remains deep.
The Street is caught between admiration for the run and discomfort with the valuation. A cluster of analysts cut targets after last quarter's results on July 30 — JPMorgan trimmed to $314 from $346 while holding Overweight, UBS moved to $300 from $350 on a Buy, and Wells Fargo lowered to $176 from $217 at Equal-Weight. Mizuho was the exception, upgrading to Outperform even as it reduced its target to $242. More recently, Jefferies raised its target to $229 from $188 in mid-August, still sitting on Hold. Bernstein reiterated Market Perform at $282 this week. The consensus mean target of $275 now sits just 9% above the current price — modest implied upside for a stock that has already tripled. On earnings quality, the factor scores tell a better story: EPS surprise ranks in the 88th percentile and 90-day EPS momentum in the 96th. The bull case centres on locked-in demand from data-centre partners like Oracle and Brookfield for rapid, reliable power. The bear case rests on valuation — a price/earnings multiple above 52x, EV/EBITDA near 44x — and competitive risk from solar-plus-storage as battery costs fall. The ORTEX short score of 38.5 ranks in the lower third, signalling the data does not flag elevated short-side pressure.
One ownership note worth carrying: SK ecoplant, the South Korean industrial group, filed a Schedule 13D/A last August disclosing a 4.7% stake — a 13D, not a 13G, which signals active rather than passive intent. That filing is now over a year old and the stake is "as last disclosed" around the 5% threshold; SK ecoplant could have reduced its position since without triggering another filing obligation. Jane Street also crossed 5% in early August with a fresh 13G, though as a market-maker its position is structural rather than directional. On the insider register, the bulk of recent activity has been sells under pre-arranged 10b5-1 plans — Director John Chambers sold 30,000 shares across two dates in August, and the CFO and CCO each trimmed smaller amounts via plans. CEO KR Sridhar executed a much smaller option-related transaction on September 1. The 90-day net insider position is negative at roughly -$22 million, but the planned nature of most sales reduces the signal value.
With the next earnings event scheduled for October 29, the period ahead is largely a valuation debate: whether the AI data-centre power demand narrative can sustain a stock trading above 52x earnings when the analyst consensus target already implies limited near-term upside from current levels.
Stocks in this article
See the live data behind this article on ORTEX.
Open BE on ORTEX →How this article was generated
- Generated
- 5 Sept 2026, 20:11
- Data as of
- 5 Sept 2026, 20:11
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.